Skip to NavigationSkip to content

Pharmafile - Research and Development News

The FDA has approved US firm Merck’s Zerbaxa (ceftolozane and tazobactam) for adults with hospital-acquired bacterial pneumonia and ventilator-...
AbbVie was one of many companies to present new data at this year’s ASCO Annual Meeting in Chicago, focusing specifically on its B-cell lymphoma-2 (...
Cases of sexually transmitted infections (STIs) are on the rise, according to new data from Public Health England.
Parents of children with cystic fibrosis have started an Orkambi buyers’ club to import generic versions of Vertex’s drug from Argentina into the...
Eli Lilly’s Emgality (galcanezumab-gnlm) self-administered injection solution has secured approval in the US for the treatment of episodic cluster...
Janssen has lifted the curtain on Phase 3 study findings for Darzalex  plus bortezomib, thalidomide and dexamethasone (VTd) before and after...
Amgen has unveiled the first clinical data for its investigational KRAS inhibitor AMG 510, the first such therapy to reach clinical stage,...
Janssen joined the showing at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago to present new data for its androgen...
Novartis has revealed new Phase 3 data on Kisqali in combination with endocrine therapy in the initial treatment of hormone receptor positive,...
New data for Biogen’s investigational therapy diroximel fumarate has been revealed at the Consortium of Multiple Sclerosis Centers (CMSC) in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches